| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |